GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | +14.3% | 190 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | -12.5% | 190 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | +14.3% | 190 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | -36.4% | 190 | -34.5% | 0.00% | – |
| Q3 2020 | $11,000 | +37.5% | 290 | +52.6% | 0.00% | – |
| Q2 2020 | $8,000 | +14.3% | 190 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 190 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +12.5% | 190 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | -100.0% | 190 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $37,561,000 | -2.3% | 935,047 | -1.9% | 0.60% | -4.0% |
| Q2 2018 | $38,437,000 | +0.4% | 953,527 | -2.7% | 0.63% | -2.8% |
| Q1 2018 | $38,299,000 | +22.4% | 980,267 | +11.1% | 0.65% | +21.2% |
| Q4 2017 | $31,285,000 | -25.5% | 882,027 | -14.7% | 0.53% | -23.7% |
| Q3 2017 | $42,002,000 | -6.7% | 1,034,532 | -0.9% | 0.70% | -9.9% |
| Q2 2017 | $45,016,000 | +5.0% | 1,043,971 | +2.6% | 0.78% | -3.8% |
| Q1 2017 | $42,885,000 | +28.9% | 1,017,202 | +17.8% | 0.81% | +24.9% |
| Q4 2016 | $33,259,000 | -16.3% | 863,647 | -6.3% | 0.65% | -13.4% |
| Q3 2016 | $39,753,000 | +23.1% | 921,705 | +23.7% | 0.75% | +12.0% |
| Q2 2016 | $32,299,000 | +14.4% | 745,241 | +7.1% | 0.67% | +6.7% |
| Q1 2016 | $28,222,000 | +25.6% | 695,974 | +25.0% | 0.62% | +18.6% |
| Q4 2015 | $22,461,000 | -1.3% | 556,647 | -6.0% | 0.53% | -2.9% |
| Q3 2015 | $22,761,000 | -4.9% | 591,961 | +3.0% | 0.54% | -0.2% |
| Q2 2015 | $23,930,000 | -2.0% | 574,557 | +8.6% | 0.54% | -2.0% |
| Q1 2015 | $24,419,000 | +88.9% | 529,113 | +75.0% | 0.56% | +79.6% |
| Q4 2014 | $12,925,000 | +15.3% | 302,399 | +24.0% | 0.31% | +5.1% |
| Q3 2014 | $11,210,000 | -10.9% | 243,844 | +3.7% | 0.29% | -7.8% |
| Q2 2014 | $12,578,000 | +0.1% | 235,185 | -0.0% | 0.32% | -5.3% |
| Q1 2014 | $12,571,000 | +2.9% | 235,274 | +2.9% | 0.34% | +1.2% |
| Q4 2013 | $12,213,000 | +11.4% | 228,748 | +4.7% | 0.33% | -0.6% |
| Q3 2013 | $10,959,000 | +8.3% | 218,438 | +7.9% | 0.34% | -10.4% |
| Q2 2013 | $10,118,000 | – | 202,487 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |